Thu, September 23, 2021
Wed, September 22, 2021
Tue, September 21, 2021

Paul Choi Downgraded (VIR) to Hold and Decreased Target to $62 on, Sep 22nd, 2021

Paul Choi of Goldman Sachs, Downgraded "Vir Biotechnology, Inc." (VIR) to Hold and Decreased Target from $64 to $62 on, Sep 22nd, 2021.

Paul has made no other calls on VIR in the last 4 months.



There is 1 other peer that has a rating on VIR. Out of the 1 peers that are also analyzing VIR, 0 agree with Paul's Rating of Hold.



This is the rating of the analyst that currently disagrees with Paul


  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $71 on, Friday, August 6th, 2021